Combination therapy with gefitinib, an epidermal growth factor receptor tyrosine kinase inhibitor, gemcitabine and cisplatin in patients with advanced solid tumors.

G. Giaccone, JL Gonzalez-Larriba, A.T. van Oosterom, R Alfonso, E.F. Smit, M. Martens, G.J. Peters, WJ van der Vijgh, R Smith, S Averbuch, A Fandi

Research output: Contribution to journalArticleAcademicpeer-review

42 Citations (Scopus)
Original languageEnglish
Pages (from-to)831-8
JournalAnnals of Oncology
Issue number5
Publication statusPublished - 2004

Cite this